Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 19, 2007
Issued Date -
N/A
app pub date -
Apr 22, 2005
filing date -
Jan 18, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Indazole compounds that modulate and/or inhibit cell proliferation, such as the activity of protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating, e.g., kinases-dependent diseases to modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.
First Claim
Other Claims data not available
